MustGrow Biologics Corp.
MGROF
$0.30
$0.000.13%
OTC PK
| 06/30/2026 | 03/31/2026 | ||||
|---|---|---|---|---|---|
| Revenue | 1,334.42% | -88.64% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 1,334.42% | -88.64% | |||
| Cost of Revenue | 0.72% | -78.82% | |||
| Gross Profit | 1,359.97% | -79.27% | |||
| SG&A Expenses | 10.86% | -49.08% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 2.94% | -58.96% | |||
| Operating Income | 161.52% | 39.40% | |||
| Income Before Tax | 146.41% | 58.38% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | 146.41% | 58.38% | |||
| Earnings from Discontinued Operations | 72.14% | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 121.08% | 36.82% | |||
| EBIT | 161.52% | 39.40% | |||
| EBITDA | 163.47% | 39.68% | |||
| EPS Basic | 120.13% | 39.84% | |||
| Normalized Basic EPS | 144.44% | 39.42% | |||
| EPS Diluted | 120.13% | 39.84% | |||
| Normalized Diluted EPS | 144.44% | 39.42% | |||
| Average Basic Shares Outstanding | 3.12% | 5.14% | |||
| Average Diluted Shares Outstanding | 3.12% | 5.14% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||